Switching to ixekizumab improves adalimumab‐induced interstitial lung disease in patients with psoriatic arthritis: A case report. Issue 1 (6th November 2020)

Record Type:: Journal Article
Title:: Switching to ixekizumab improves adalimumab‐induced interstitial lung disease in patients with psoriatic arthritis: A case report. Issue 1 (6th November 2020)
Main Title:: Switching to ixekizumab improves adalimumab‐induced interstitial lung disease in patients with psoriatic arthritis: A case report
Authors:: Hayashi, Hideki
Kusakabe, Minori
Nagai, Makoto
Imai, Yasutomo
Yamanishi, Kiyofumi
Abstract:: Abstract : A case of adalimumab‐induced interstitial lung disease that was successfully controlled with ixekizumab in a patient with psoriatic arthritis.
Is Part Of:: Journal of cutaneous immunology and allergy. Volume 4:Issue 1(2021)
Journal:: Journal of cutaneous immunology and allergy
Issue:: Volume 4:Issue 1(2021)
Issue Display:: Volume 4, Issue 1 (2021)
Year:: 2021
Volume:: 4
Issue:: 1
Issue Sort Value:: 2021-0004-0001-0000
Page Start:: 22
Page End:: 23
Publication Date:: 2020-11-06
Subjects:: Skin -- Diseases -- Immunological aspects -- Periodicals
Skin -- Diseases -- Periodicals
Skin -- Diseases -- Treatment -- Periodicals
616.5079
Journal URLs:: https://onlinelibrary.wiley.com/journal/25744593 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/cia2.12146 ↗
Languages:: English
ISSNs:: 2574-4593
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 15986.xml